THRX

Theravance, Inc. News Headlines

$22.89
*  
0.67
2.84%
Get THRX Alerts
*Delayed - data as of Sep. 2, 2014  -  Find a broker to begin trading THRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    THRX After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Glaxo, Theravance File Asthma Drug Application with FDA
6/30/2014 8:43:00 AM - Dow Jones Business News

GSK And Theravance Announce Submission Of SNDA To FDA For FF/VI In Asthma
6/30/2014 8:28:00 AM - RTT News

GSK, Theravance Report Positive Data From Two Studies Involving Incruse Ellipta
6/11/2014 8:08:00 AM - RTT News

GlaxoSmithKline Posts Positive Results for Pulmonary Disease Drug
6/11/2014 8:04:00 AM - Dow Jones Business News

Seth Klarman's Baupost: Investment Changes During The First Quarter
5/19/2014 11:40:00 AM - Seeking Alpha

Tracking Seth Klarman's Baupost Group Holdings - Q1 2014 Update
5/15/2014 4:18:00 AM - Seeking Alpha

Split Update Overshadows Wider Q1 Loss at Theravance - Analyst Blog
5/7/2014 11:40:01 AM - Zacks.com

Update on Glaxo/Theravance's COPD Drugs - Analyst Blog
4/24/2014 6:33:01 PM - Zacks.com

Has Theravance Just Given Away 40% Of Its Value?
4/22/2014 8:43:00 AM - Seeking Alpha

Sector Update: Health Care
4/21/2014 8:22:04 AM - MT Newswires

Sector Update: Health-Care Shares Flat Pre-Market; Sarepta Soars 75% on New Drug Application Plans for Eteplirsen
4/21/2014 8:18:57 AM - MT Newswires

Why You Should Still Be Considering A Bio-Tech Stock, But With A Sensible Hedge
4/14/2014 10:13:00 AM - Martin Tillier

First Week of THRX April 19th Options Trading
4/7/2014 11:25:08 AM - BNK Invest

Theravance Is A Classic Ben Graham Bargain
4/4/2014 8:25:00 AM - Seeking Alpha

Theravance: Baby Thrown Out With The Bath Water - 35% To 65% Upside
3/31/2014 2:48:00 PM - Seeking Alpha

First Week of May 17th Options Trading For Theravance (THRX)
3/27/2014 1:01:41 PM - BNK Invest

Theravance Larger Than S&P 500 Component International Game Technology
3/26/2014 4:44:06 PM - BNK Invest

Glaxo/Theravance Update on COPD Drugs - Analyst Blog
3/18/2014 6:30:01 PM - Zacks.com

Update on Glaxo's Pipeline - Analyst Blog
3/17/2014 1:53:01 PM - Zacks.com

Theravance to Split in Q2 - Analyst Blog
3/4/2014 1:00:01 PM - Zacks.com

THRX Crosses Below Key Moving Average Level
2/28/2014 5:43:00 PM - BNK Invest

Update on Teva's DuoResp Spiromax - Analyst Blog
2/25/2014 7:00:01 PM - Zacks.com

CHMP Positive on Glaxo's Two Drugs - Analyst Blog
2/21/2014 5:45:01 PM - Zacks.com

Glaxo's COPD Drug Gets European Green Light
2/20/2014 9:41:00 AM - Fox Business

Tracking Seth Klarman's Baupost Group Holdings - Q4 2013 Update
2/14/2014 3:01:00 AM - Seeking Alpha